166 related articles for article (PubMed ID: 30008917)
1. Prognostic significance of the expression of HER family members in primary osteosarcoma.
Wang SL; Zhong GX; Wang XW; Yu FQ; Weng DF; Wang XX; Lin JH
Oncol Lett; 2018 Aug; 16(2):2185-2194. PubMed ID: 30008917
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma.
Zhong G; Wang Y; Wei H; Chen M; Lin H; Huang Z; Huang J; Wang S; Lin J
Int J Gen Med; 2021; 14():6477-6485. PubMed ID: 34675615
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.
Huang Z; Wang SL; Chen H; Shen RK; Li XD; Huang QS; Wu CY; Weng DF; Lin JH
Scand J Clin Lab Invest; 2019 Dec; 79(8):601-612. PubMed ID: 31663373
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of HER family members in patients with Dukes' C and D colon cancer and their impacts on patient prognosis and survival.
Khelwatty SA; Essapen S; Bagwan I; Green M; Seddon AM; Modjtahedi H
PLoS One; 2014; 9(3):e91139. PubMed ID: 24609222
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.
Shi K; Wang SL; Shen B; Yu FQ; Weng DF; Lin JH
World J Surg Oncol; 2019 Jan; 17(1):23. PubMed ID: 30691475
[TBL] [Abstract][Full Text] [Related]
6. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of the recepteur d'origine nantais (RON) expression in primary high-grade osteosarcoma.
Wang SL; Weng DF; Wei HX; Huang Z; Lin RQ; Shi K; Lin JH
J Orthop Sci; 2021 Nov; 26(6):1100-1106. PubMed ID: 32972820
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
Huang H; Zheng HY; Liu ZL; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
[TBL] [Abstract][Full Text] [Related]
9. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
11. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
Zhang B; Pang QJ; Zhang HJ; Yuan Y
Zhongguo Gu Shang; 2011 Dec; 24(12):982-6. PubMed ID: 22276503
[TBL] [Abstract][Full Text] [Related]
12. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
13. Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma.
Hughes DP; Thomas DG; Giordano TJ; Baker LH; McDonagh KT
Cancer Res; 2004 Mar; 64(6):2047-53. PubMed ID: 15026342
[TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.
Selvarajah GT; Verheije MH; Kik M; Slob A; Rottier PJ; Mol JA; Kirpensteijn J
Vet J; 2012 Aug; 193(2):412-9. PubMed ID: 22436430
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.
Wang Y; Wang N; Zeng X; Sun J; Wang G; Xu H; Zhao W
Oncol Lett; 2017 May; 13(5):3057-3065. PubMed ID: 28521412
[TBL] [Abstract][Full Text] [Related]
16. A Retrospective Clinicopathological Study of Osteosarcoma Patients with Metachronous Metastatic Relapse.
Bao J; Zeng J; Song C; Yu H; Shi Q; Mai W; Qu G
J Cancer; 2019; 10(13):2982-2990. PubMed ID: 31281475
[No Abstract] [Full Text] [Related]
17. HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
Makatsoris T; Tsamandas AC; Strimpakos A; Alexopoulou Z; Dionysopoulos D; Pervana S; Konstantara A; Papakostas P; Samantas E; Rallis G; Dimou A; Pentheroudakis G; Papaparaskeva K; Psyrri A; Kalogeras KT; Syrigos K; Scopa CD; Fountzilas G
Anticancer Res; 2016 Apr; 36(4):1581-90. PubMed ID: 27069134
[TBL] [Abstract][Full Text] [Related]
18. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
[TBL] [Abstract][Full Text] [Related]
19. Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma.
Chao L; Liu J; Zhao D
Oncol Lett; 2017 May; 13(5):2891-2896. PubMed ID: 28521394
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic significance of S100A4 expression in osteosarcoma.
Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
